Arachidonic Acid - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The arachidonic acid market size was valued at USD 262.12 million in 2025 and estimated to grow from USD 272.76 million in 2026 to reach USD 332.92 million by 2031, at a CAGR of 4.06% during the forecast period (2026-2031). This report is Segmented by Source (Microbial, Animal-Derived, and Plant-Based), Form (Liquid Oil, Powder, and Emulsion), Application (Infant Formula, Dietary Supplements, Functional Beverages, Pharmaceuticals, Aquaculture and Animal Feed, and Cosmetics and Personal Care), and by Geography. The Market Forecasts are Provided in Terms of Value (USD).

Global Arachidonic Acid Market Trends and Insights

Rising demand for arachidonic acid (ara)-fortified infant formula

Surging demand for ARA-fortified infant formulas is driving the global ARA market's growth. ARA, an essential omega-6 fatty acid found naturally in breast milk, is pivotal for infant brain development, immune function, and visual acuity. With rising awareness of early-life nutrition, parents and healthcare providers increasingly favor infant formulas that mimic human milk's nutritional profile, emphasizing both DHA and ARA. This trend is notably strong in regions like Asia-Pacific, Latin America, and Africa, where breastfeeding rates are declining or birth rates are on the rise. These areas are witnessing a heightened demand for premium, nutritionally complete infant formulas. For context, the Central Intelligence Agency reported that in 2024, Niger boasted the world's highest birth rate at 46.6 births per 1,000 inhabitants, followed by Angola, Benin, Mali, and Uganda. Regulatory bodies and scientific endorsements have underscored ARA's significance in infant nutrition, leading more formula manufacturers to integrate it into their offerings. Consequently, ARA has emerged as a vital ingredient in the infant nutrition landscape, fueling the global ARA market's expansion.

Growing health consciousness and dietary supplement use

Global health consciousness is on the rise, and with it, the demand for dietary supplements. As consumers increasingly recognize the significance of targeted nutrition for their well-being, the demand for functional ingredients especially those supporting cognitive health, immune function, and inflammatory responses has surged. Arachidonic acid (ARA) is pivotal in these areas. For instance, a 2023 survey by the Council for Responsible Nutrition (CRN) revealed that a record 74% of United States adults turned to dietary supplements. Fitness enthusiasts and athletes are gravitating towards ARA-based supplements, drawn by their potential to boost muscle growth, strength, and recovery, solidifying ARA's place in sports nutrition. Meanwhile, an aging population is on the lookout for supplements to bolster brain and cardiovascular health. Given ARA's role in neural signaling and anti-inflammatory processes, it's no wonder interest in ARA is intensifying. This heightened demand has led supplement manufacturers to blend ARA into capsules, softgels, and powders, often pairing it with DHA and other omega fatty acids for a holistic health approach. Consequently, as health awareness grows and proactive supplementation becomes the norm, the global ARA market is witnessing a broad expansion across diverse consumer demographics.

Competition from alternative omega-6 fatty acid sources

Alternative sources of omega-6 fatty acids are challenging the growth of the global arachidonic acid (ARA) market. These alternatives are not only more cost-effective but also more readily available and scalable for both manufacturers and consumers. ARA is known for its unique physiological benefits, especially concerning neural and immune functions. However, other omega-6 fatty acids, like linoleic acid, are proving to be more economically viable. Linoleic acid is abundant in vegetable oils, including soybean, sunflower, and corn oil. For context, the USDA Foreign Agricultural Service reported that in the 2023/24 period, global usage of soybean oil exceeded 63.87 million metric tons. Due to their lower production costs and well-established supply chains, these alternative omega-6s are frequently incorporated into functional foods, dietary supplements, and infant nutrition products. Additionally, regulatory and consumer concerns regarding excessive omega-6 intake especially its potential association with pro-inflammatory effects have prompted manufacturers to adopt a more balanced omega profile. This often means reducing or substituting ARA with other fatty acids. As a result, the competitive edge of these more affordable and accessible omega-6 sources is curtailing ARA's penetration into the mass market. This limitation is stifling ARA's broader acceptance in mainstream nutritional and pharmaceutical products, ultimately hindering its market growth.

Other drivers and restraints analyzed in the detailed report include:

• Increasing geriatric population and lifestyle-related disorders
• Consumer preference for functional lipids and omega fatty acids
• High production costs associated with extraction and processing

Segment Analysis

Microbial sources generated 41.91% of the arachidonic acid market in 2025 dominating the market. Food and cosmetic manufacturers favor microbial-based arachidonic acid (ARA) for its unmatched consistency, scalability, and purity. By employing microbial fermentation, often with fungi such as Mortierella alpina, producers can achieve high-quality ARA in a controlled manner, sidestepping the inconsistencies tied to animal or plant sources. This precision is paramount in sectors like infant nutrition and cosmetics, where safety, allergen management, and regulatory adherence are non-negotiable. Beyond quality, microbial-based ARA resonates with sustainability and ethical considerations, aligning seamlessly with vegan and clean-label movements, thus appealing to both producers and consumers.

The plant-based lines, though niche, clock the fastest 5.99% CAGR through 2031, leveraging CRISPR and algae photobioreactors. On the other hand, the demand for plant-based ARA is on the rise. This surge is fueled by biotechnological advancements and refined extraction methods, enhancing yields from genetically modified plants or algae. Coupled with the growing popularity of plant-based diets, a consumer shift towards natural and eco-friendly ingredients, and regulatory pushes to minimize synthetic or animal-derived dependencies, the momentum is undeniable. In this evolving landscape, while microbial-based ARA reigns supreme in industrial applications for its reliability, plant-based ARA is carving out a significant niche, championing the ideals of clean, green, and ethical nutrition and personal care.

Complete Report Scope:

• By Source
  • Microbial
  • Animal-derived
  • Plant-based
• By Form
  • Liquid Oil
  • Powder
  • Emulsion
• By Application
  • Infant Formula
  • Dietary Supplements
  • Functional Beverages
  • Pharmaceuticals
  • Aquaculture and Animal Feed
  • Cosmetics and Personal Care
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

In 2025, North America held a dominant 30.92% market share, bolstered by established formula brands and strong GRAS pathways. North America's stable policies and established retail channels have paved the way for the early adoption of functional lipids. The FDA's GRAS notifications, which encompass a range of ARA-rich oils, provide formulators with a clear market entry route. Canada's acceptance of Ahiflower oil highlights its receptiveness to new fatty acids, inadvertently intensifying competition and driving quality enhancements among ARA suppliers.

Meanwhile, Asia-Pacific, with a 5.59% CAGR, benefited from rising disposable incomes, favorable demographics, and a rapidly expanding aquaculture sector. Updates to China's GB regulations are pushing local producers to reformulate, leading to a surge in short-term ingredient orders. Asia-Pacific stands out for its scale and rapid pace: China's stricter standards are amplifying the urgency for global sourcing, and in India, reductions in feed tariffs are enhancing aquaculture's profitability. Japan's older demographic is increasingly purchasing fortified foods, underscoring a growing demand for adult nutrition. Meanwhile, Australia's rigorous clean-label regulations are favoring high-purity imports, benefiting suppliers who can demonstrate microbiological controls. Together, these dynamics are shifting the arachidonic acid market towards a more diversified set of demand centers.

Europe's 1% cap on fat-based ARA, coupled with EFSA's ongoing review, poses stringent compliance challenges for manufacturers operating in the region. These regulatory measures, however, play a crucial role in ensuring product safety and quality, thereby bolstering foundational demand for compliant products. Germany and France, recognized for their strong preference for premium organic formulas, lead the region in consumption, reflecting a growing consumer inclination toward high-quality and sustainable options. Furthermore, European retailers are increasingly committing to sustainability goals, which are driving a shift toward microbial sourcing of ingredients. This transition not only aligns with environmental objectives but also significantly reduces the carbon footprint associated with the reliance on imported fish oils, offering a more eco-friendly alternative for the market.

List of Companies Covered in this Report:

• Cargill, Incorporated
• DSM-Firmenich AG
• BASF SE
• Cabio Biotech
• Guangdong Runke
• Merck Group
• Cayman Chemical
• Suntory Holdings
• Qingdao Seawit Life Science
• Zhejiang Weile Biotech
• Hubei Fuxing Biotechnology
• LGM Pharma
• Avantor Sciences
• Thermo Fisher Scientific
• CABIO Biotech (Wuhan) Co., Ltd
• Shandong New Element Biotechnology Co., Ltd.
• Hefei TNJ Chemical Industry Co.,Ltd.,
• Xi'an Healthful Biotechnology Co.,Ltd
• BIOWAY Industrial Group LTD
• Xi'an Biof Bio-Technology Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support